Hematologic Malignancy
227
66
80
76
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
34 trials with published results (15%)
Research Maturity
76 completed trials (33% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.8%
20 terminated out of 227 trials
79.2%
-7.3% vs benchmark
5%
11 trials in Phase 3/4
45%
34 of 76 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 76 completed trials
Clinical Trials (227)
Response to Influenza Vaccination in Pediatric Oncology Patients
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.
Intervention for Fatigue in HCT Recipients
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
The Oronasal Microbiota in Pediatric Oncology Patients
Global Cardio Oncology Registry
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Expressive Writing Program Among Young Adults With Blood Cancer
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients